← Back to patent-cliff list
盐酸普索洛尔/盐酸毛果芸香碱
Tier C — Watch / tradeProxodolol hydrochloride/Pilocarpine Hydrochloride
Moscow Endocrine Plant
Originator
2006
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：β-adrenoceptors、mAChRs、α-adrenoceptors
Brand：Proxocarpin、Proxocarpine、Proksokarpin、Proksocarpin
Indications (approved)：青光眼
Regional status
US
-
EU
批准上市
2006-05-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Proxodolol hydrochloride/Pilocarpine Hydrochloride?
Approved indications include: 青光眼.
When does the Proxodolol hydrochloride/Pilocarpine Hydrochloride patent expire?
No public expiry year is available for Proxodolol hydrochloride/Pilocarpine Hydrochloride yet; this page updates once verified.
How do I get a quote for Proxodolol hydrochloride/Pilocarpine Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24